BVS Logo

Bioventus Inc. (BVS) 

NASDAQ
Market Cap
$762.52M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
116 of 775
Rank in Industry
13 of 99

Largest Insider Buys in Sector

BVS Stock Price History Chart

BVS Stock Performance

About Bioventus Inc.

Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for …

Insider Activity of Bioventus Inc.

Over the last 12 months, insiders at Bioventus Inc. have bought $901,702 and sold $389,358 worth of Bioventus Inc. stock.

On average, over the past 5 years, insiders at Bioventus Inc. have bought $2.89M and sold $595,907 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Bartholdson John A. () — $901,702.

The last purchase of 25,500 shares for transaction amount of $217,966 was made by Bartholdson John A. () on 2024‑08‑19.

List of Insider Buy and Sell Transactions, Bioventus Inc.

2024-08-19Purchase
25,500
0.0418%
$8.55$217,966+43.00%
2024-08-16Purchase
80,000
0.1383%
$8.55$683,736+1.25%
2024-06-21SaleSVP & General Counsel
5,904
0.0079%
$5.57$32,885+95.94%
2024-06-21SaleSVP & CFO
9,219
0.0123%
$5.57$51,350+95.94%
2024-06-21SaleSVP & Chief Compliance Officer
2,559
0.0034%
$5.57$14,254+95.94%
2024-06-17SaleSVP & General Counsel
11,308
0.0158%
$5.84$66,039+83.67%
2024-06-17SaleSVP & CFO
13,753
0.0193%
$5.84$80,318+83.67%
2024-06-17SaleSVP & Chief Compliance Officer
8,759
0.0123%
$5.84$51,153+83.67%
2024-04-11SaleSVP & General Counsel
3,054
0.0048%
$4.75$14,507+54.89%
2024-04-11SaleSVP & CFO
4,000
0.0062%
$4.75$19,000+54.89%
2024-04-11SaleSVP & Chief Compliance Officer
1,325
0.0021%
$4.75$6,294+54.89%
2024-03-22SaleSVP & CFO
5,541
0.0087%
$5.39$29,853+29.32%
2024-03-15SaleSVP & General Counsel
3,125
0.0049%
$5.46$17,063+25.69%
2024-03-15SaleSVP & Chief Compliance Officer
1,217
0.0019%
$5.46$6,645+25.69%
2023-08-18PurchaseInterim CEO
39,885
0.0603%
$4.14$165,076+7.76%
2023-08-14Purchase10 percent owner
14,985
0.0242%
$4.79$71,778-1.05%
2023-08-14Purchase
14,985
0.0242%
$4.79$71,753-1.05%
2023-08-11Purchase10 percent owner
50,037
0.0807%
$4.56$228,169+3.76%
2023-08-11Purchase
50,037
0.0813%
$4.60$229,935+3.76%
2023-08-10Purchase10 percent owner
111,848
0.1762%
$4.47$499,961+2.41%

Insider Historical Profitability

22.07%
Bartholdson John A.
6939357
10.6159%
$11.67110+55.37%
D'Adamio AnthonySVP & General Counsel
95576
0.1462%
$11.6717<0.0001%
CHURCH KATRINA JSVP & Chief Compliance Officer
41199
0.063%
$11.67110<0.0001%
Juniper Investment Company, LLC10 percent owner
6833857
10.4545%
$11.6730
HAWKINS WILLIAM Adirector
184310
0.282%
$11.6720+54.75%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Essex Woodlands Management Inc$67.71M16.3613.02M0%+$019.68
Juniper Investment Company$35.54M8.586.83M0%+$017.68
Nantahala Capital Management Llc$30.19M7.295.81M-2.87%-$891,586.791.41
The Vanguard Group$6.34M1.531.22M0%+$0<0.0001
Millennium Management LLC$2.86M0.69549,432+133.32%+$1.63M<0.01
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.